Form 4: Elevance Health Director Antonio F. Neri Acquires Deferred Stock Units
SEC Form 4 Filing
Director Antonio F. Neri acquired 601 deferred stock units of Elevance Health, Inc. under the company's Board of Directors Compensation Program.
Summary
- On May 14, 2025, Antonio F. Neri, a director of Elevance Health, Inc., acquired 601 deferred stock units.
- The acquisition was made under the Elevance Health, Inc. Board of Directors Compensation Program.
- These deferred stock units will be payable in company common stock either five years from the grant date or upon cessation of board membership, unless a later date is designated.
- Following the transaction, Neri directly owns 4,925 shares of Elevance Health common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and alignment of interests. There are no indications of negative events or concerns.
Positives
- The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
- The director's continued holding of Elevance Health common stock demonstrates confidence in the company's future.
Future Outlook
The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Industry Context
This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies. It reflects standard practices for aligning director interests with shareholder value.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders by aligning director interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of transaction: Antonio F. Neri acquired 601 deferred stock units. |
| 05/16/2025 | Date of signature on the Form 4 filing. |
Keywords
Elevance Health, Director, Stock Units, Deferred Stock, Beneficial Ownership, Form 4, ELV, Compensation Program
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.